Amvuttra Archives - Inside Precision Medicine

Inside Precision Medicine Alnylam’s Vutrisiran Gets Good Results for Cardiac Amyloidosis

Image of a heart with a DNA double helix in front of it to indicate cardiovascular disease and the impact of transthyretin amyloid cardiomyopathy (ATTR-CM) which can be treated with vutrisiran.

News & Features

Alnylam’s Vutrisiran Gets Good Results for Cardiac Amyloidosis

June 24, 2024

Related Content

Atherosclerotic Plaque Mapping Could Predict Stroke or Heart Attack Risk

Atherosclerotic Plaque Mapping Could Predict Stroke or Heart Attack Risk

BridgeBio’s Attruby Approved for Rare Heart Disease

BridgeBio’s Attruby Approved for Rare Heart Disease

Innovative Packaging of mRNA Therapeutics Improves Their Delivery and Speeds Development

Innovative Packaging of mRNA Therapeutics Improves Their Delivery and Speeds Development

Lipoprotein(a) Lowering Draw Between Lilly and Silence

Lipoprotein(a) Lowering Draw Between Lilly and Silence